Brian C. Broderick’s Gilead Sciences GILD Stock Holding History

Brian C. Broderick’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$461K	Buy	+3,310	New	+$464K	0.09%	76
2018 Q4	–	Sell	-8,735	Closed	-$675K	–	79
2018 Q3	$675K	Sell	8,735 -8,123	-48%	-$613K	0.23%	59
2018 Q2	$1.19M	Buy	16,858 +35	+0.2%	+$2.47K	0.44%	53
2018 Q1	$1.27M	Buy	16,823 +418	+3%	+$33.2K	0.48%	51
2017 Q4	$1.18M	Sell	16,405 -258	-2%	-$19.6K	0.43%	54
2017 Q3	$1.35M	Sell	16,663 -300	-2%	-$22.9K	0.49%	56
2017 Q2	$1.2M	Buy	16,963 +160	+1%	+$10.6K	0.44%	55
2017 Q1	$1.14M	Buy	16,803 +1,320	+9%	+$92.8K	0.47%	51
2016 Q4	$1.11M	Sell	15,483 -1,125	-7%	-$83.6K	0.48%	52
2016 Q3	$1.31M	Buy	16,608 +905	+6%	+$73.5K	0.56%	49
2016 Q2	$1.31M	Buy	15,703 +5,879	+60%	+$522K	0.55%	50
2016 Q1	$902K	Buy	+9,824	New	+$886K	0.39%	57
2015 Q4	–	Sell	-60	Closed	-$6K	–	102
2015 Q3	$6K	Hold	60	–	–	﹤0.01%	103
2015 Q2	$7K	Hold	60	–	–	﹤0.01%	102
2015 Q1	$6K	Buy	+60	New	+$6.09K	﹤0.01%	104

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Brian C. Broderick's GILD Position: Q1 2026 in Review

Brian C. Broderick opened a new position in Gilead Sciences (GILD) in Q1 2026: 3,310 shares worth $461K. The stake represents 0.09% of the portfolio and ranks #76 among its holdings. This is a return to the name: Brian C. Broderick previously reported a position in GILD as recently as Q3 2018.

Brian C. Broderick first reported a position in GILD in Q1 2015 and has held it in 15 quarters since. The position peaked at $1.35M in Q3 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Brian C. Broderick held 3,310 shares of Gilead Sciences worth $461K as of Q1 2026.
Gilead Sciences was a new Brian C. Broderick position in Q1 2026.
Gilead Sciences made up 0.09% of Brian C. Broderick's portfolio in Q1 2026, its #76 holding.
Brian C. Broderick first reported a position in Gilead Sciences in Q1 2015 and has held it in 15 quarters since.
Brian C. Broderick's Gilead Sciences position peaked at $1.35M in Q3 2017.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.